RNA Transcript Study Identifies Shared Ageing Patterns Across Species
Researchers examined RNA transcripts from rodents, monkeys, and humans. The work identified common molecular signatures associated with ageing.
manilatimes.netA study published in Nature analyzed RNA transcripts collected from rodents, monkeys, and humans. The analyses identified recurring molecular patterns linked to ageing across the three groups. The patterns, described as hallmarks of ageing, were consistent enough that the authors suggested they could help guide future research on interventions.
Samples came from multiple tissues in each species.
The study compared transcript levels at different ages within each species and then looked for overlaps between species. Researchers reported that certain transcripts changed in similar directions and magnitudes during ageing, regardless of the organism examined.
The authors stated that these shared signatures might shorten the time needed to test candidate anti-ageing compounds. They noted that the findings provide a reference set of molecular changes that could be measured in future experiments. No specific interventions were tested in the reported work.
Key Facts
Potential Impact
- 01
Future studies may use the reported signatures as reference points when screening compounds.
Transparency Panel
Related Stories
NprWHO Director Visits Congo as Ebola Outbreak Spreads
The head of the World Health Organization arrived in Kinshasa to support efforts against a rare Ebola strain. Health workers face equipment shortages, community distrust, and armed conflict in affected provinces.
medpagetoday.comFDA Panel Recommends XFG Variant for Fall Covid Shots
Replimune will submit an application to the FDA for the third time. Pfizer and Innovent Biologics reached a collaboration agreement valued at up to $10.5 billion.
Benzinga Publishes Article on Biotech Stocks During Pandemic Recovery
Benzinga published an article titled 'Best Biotech Stocks Right Now' that addresses the sector's position during global recovery from the pandemic. The piece notes government institutions and professional traders are focusing on biotech companies for vaccine and booster developme…